How do we move on from FISH testing in #myeloma ? Dr. Ben Diamond teaches us how at the Miami HealthTree Roundtable. #mmsm

We are going to Houston! See you there on May 9th
📍Houston, TX: buff.ly/4d0puHf

Krina Patel MD Anderson Cancer Center

#healthtree #bloodcancers #leukemia #lymphoma #myeloma #multiplemyeloma #smolderingmyeloma #mgus #cll #mds #aml #myelofibrosis #follicularlymphoma #dlbcl

U of Miami is so fortunate to now have Dr. Damian Green in the myeloma group. As a CAR T expert he is helping move the field forward. “CAR T is in its infancy.” #mmsm

Thrilled to be in Miami at the HealthTree Myeloma Roundtable learning about bispecific antibodies from Dr. David Coffey from U of Miami. #mmsm

See you on May 7th!🗓

Cure Tour📍Dallas, TX: buff.ly/3xJrQKz

Gurbakhash Kaur UTSW Simmons Cancer Center
#healthtree #bloodcancers #leukemia #lymphoma #myeloma #multiplemyeloma #smolderingmyeloma #mgus #cll #mds #aml #myelofibrosis #follicularlymphoma #dlbcl

Congrats to Dr. Jay Hydren on becoming an Active Member of ASH! Excited for the doors this opens to share impactful research from #HealthTreeCureHub patients.

The HealthTree Cure Tour is starting in May!🥳 Click on the link to find out more about the Cure Tour in our first stop:📍Syracuse, NY: buff.ly/3W5GLce with Ehsan Malek and Dr. Krishna Ghimire
Roswell Park Upstate Medical University
#HealthtreeCureTour #myeloma #leukemia #lymphoma

The Food and Drug Administration (FDA) announced the approval of two BCMA-directed multiple myeloma CAR T-cell therapies for use by relapsed and refractory patients. Learn more: buff.ly/4aZf5tH

100% of your donation will support HealthTree's groundbreaking research tools, HealthTree Cure Hub and HealthTree Research Hub. Donate here: buff.ly/4axTb0L
Urvi Shah, Tanya Wildes MD, Annette Hay, Attaya Suvannasankha, Dr.MHB, Gurbakhash Kaur, Meera Mohan, Sarah Ryan

Save the date🔔 We're going to Charlotte on Mary 4th. Registration is OPEN! Find more info here: buff.ly/3W1ylCE Luciano J Costa Dr.MHB

#MDS The FDA recently announced that relapsed or refractory MDS has responded well enough in the Phase 1 trial of bexmarilimab, that the advancement to Phase 2 will begin in Finland and the U.S. Read more: buff.ly/4cIW5RP

#HealthTreeMDS #mdssm #hematology #bloodcancer

Hear ten case-based sessions presented by expert #Oncology nurses, who will provide real-world insights on modern patient assessment, treatment selection, dosing & scheduling, & AE management for #MultipleMyeloma . 4/26 at 5:30 AM EDT: buff.ly/49L2eLp #ONS2024 PeerView

#MYELOMA : We're only 2 weeks away from the Miami HealthTree Roundtable. Register for in-person event or virtual to get the recording after. Link to register: buff.ly/49y6hu3
Sylvester Comprehensive Cancer Center
C. Ola Landgren, M.D.
Ben Diamond, MD

#Myelofibrosis is often characterized by anemia, spleen enlargement, fatigue, night sweats and bone pain. These symptoms can be extremely burdensome. Read more here: buff.ly/3PQqHXO

#healthtree MF #healthtree #MF #bloodcancer #MPN #myeloproliferativeneoplasms

Epkinly is currently being administered in a clinical trial to treat relapsed/refractory CLL patients. The data so far shows promising results, helping 67% of high-risk CLL patients achieve remission with manageable side effects. Learn more here: buff.ly/3xl8xad

Dr. Koehne, the Deputy Director of Miami Cancer Institute, discusses the changing landscape of AML treatment, including the use of novel targeting agents for patients. Read more here: buff.ly/3VKSmwR

#HealthTreeAML #amlsm #acutemyeloidleukemia #bloodcancer

#AML A new trial, Race Oncology has recently announced promising results for a Phase 2 trial for relapsed/refractory AML patients. Bisantrene is used in combination with fludarabine and clofarabine in relapsed or refractory acute myeloid leukemia patients. buff.ly/4agbFT6

Today on National Doctor's Day, we thank all those who save lives every day. We appreciate your attention and dedication! #nationaldoctorsday #doctor #healthtree #bloodcancer #hematology

The U.S. Food and Drug Administration (FDA) granted accelerated approval to zanubrutinib for treating adult patients with relapsed or refractory follicular lymphoma. Learn more here: buff.ly/4ab744B

#AML A new study is set to investigate the combination of danvatirsen and venetoclax, as well as danvatirsen monotherapy. Read more here: buff.ly/4agb4kk

#HealthTreeAML #aml #aml sm #acutemyeloidleukemia #bloodcancer #bloodcancer awareness #leukemia #hematology